HRP20131104T1 - Metoda širenja za odrasle matiäśne stanice iz krvi, posebno periferne krvi, te relativna uporaba u medicinskom podruäśju - Google Patents

Metoda širenja za odrasle matiäśne stanice iz krvi, posebno periferne krvi, te relativna uporaba u medicinskom podruäśju Download PDF

Info

Publication number
HRP20131104T1
HRP20131104T1 HRP20131104TT HRP20131104T HRP20131104T1 HR P20131104 T1 HRP20131104 T1 HR P20131104T1 HR P20131104T T HRP20131104T T HR P20131104TT HR P20131104 T HRP20131104 T HR P20131104T HR P20131104 T1 HRP20131104 T1 HR P20131104T1
Authority
HR
Croatia
Prior art keywords
mammals
concentration
mcsf
recommended
stem cells
Prior art date
Application number
HRP20131104TT
Other languages
English (en)
Croatian (hr)
Inventor
Alessandra Gambacurta
Marco Polettini
Original Assignee
Thankstem S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thankstem S.R.L. filed Critical Thankstem S.R.L.
Publication of HRP20131104T1 publication Critical patent/HRP20131104T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
HRP20131104TT 2006-09-20 2007-09-11 Metoda širenja za odrasle matiäśne stanice iz krvi, posebno periferne krvi, te relativna uporaba u medicinskom podruäśju HRP20131104T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000498A ITRM20060498A1 (it) 2006-09-20 2006-09-20 Metodo di espansione di cellule staminali adulte da sangue periferico e relativi usi in campo medico
PCT/EP2007/059531 WO2008034740A1 (en) 2006-09-20 2007-09-11 Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field

Publications (1)

Publication Number Publication Date
HRP20131104T1 true HRP20131104T1 (hr) 2013-12-20

Family

ID=38126399

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20131104TT HRP20131104T1 (hr) 2006-09-20 2007-09-11 Metoda širenja za odrasle matiäśne stanice iz krvi, posebno periferne krvi, te relativna uporaba u medicinskom podruäśju

Country Status (20)

Country Link
US (2) US8263400B2 (cg-RX-API-DMAC7.html)
EP (1) EP2076588B1 (cg-RX-API-DMAC7.html)
JP (1) JP5340941B2 (cg-RX-API-DMAC7.html)
KR (1) KR101570446B1 (cg-RX-API-DMAC7.html)
CN (1) CN101553565B (cg-RX-API-DMAC7.html)
AU (1) AU2007299043B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0715036A2 (cg-RX-API-DMAC7.html)
CA (1) CA2663072C (cg-RX-API-DMAC7.html)
DK (1) DK2076588T3 (cg-RX-API-DMAC7.html)
EA (1) EA019305B1 (cg-RX-API-DMAC7.html)
ES (1) ES2435080T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20131104T1 (cg-RX-API-DMAC7.html)
IL (1) IL197575A (cg-RX-API-DMAC7.html)
IT (1) ITRM20060498A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009003059A (cg-RX-API-DMAC7.html)
PL (1) PL2076588T3 (cg-RX-API-DMAC7.html)
RS (1) RS53039B (cg-RX-API-DMAC7.html)
SI (1) SI2076588T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008034740A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200901748B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132116B2 (en) * 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
ITUD20080058A1 (it) * 2008-03-18 2009-09-19 Thankstem S R L Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali
WO2010126544A1 (en) * 2009-04-29 2010-11-04 Willowcroft Pharm, Llc Mast cell stabilizers to prevent or treat laminitis
KR101202836B1 (ko) * 2010-08-27 2012-11-20 서울대학교산학협력단 세포응집을 이용한 인간 혈액 유래 혈구 세포괴의 유도와 이를 이용한 혈중 성체줄기세포 및 전구세포의 증폭방법 및 상기의 방법에 의해 제조된 줄기세포
CA2863556A1 (en) * 2011-01-31 2012-08-09 Henry E. Young Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
BE1020480A5 (nl) 2012-10-01 2013-11-05 Global Stem Cell Technology Werkwijze voor de isolatie van mesenchymale stamcellen uit bloed van zoogdieren, en gebruik ervan.
ES2690253T3 (es) * 2014-05-09 2018-11-20 Thankstem S.R.L. Método para expandir células madre adultas a partir de sangre entera
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2016204230A1 (ja) * 2015-06-17 2016-12-22 仁幸 小林 幹細胞投与方法、競走馬または競技馬の症状改善方法、注射用容器および幹細胞注射セット
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
AU2017281631B2 (en) * 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
US11103537B2 (en) 2016-06-23 2021-08-31 Tithon Biotech Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
WO2020234910A1 (en) * 2019-05-22 2020-11-26 Thankstem S.R.L. Method for expanding adult stem cells from whole blood

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1436843A (zh) * 2002-02-08 2003-08-20 刘颉 脐血造血干细胞的制作方法
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
WO2004043990A2 (en) * 2002-11-07 2004-05-27 University Of Chicago Human stem cell materials and methods
CN1667119A (zh) * 2004-03-11 2005-09-14 中国人民解放军第二军医大学 一种成体干细胞及其培养方法和用途

Also Published As

Publication number Publication date
KR101570446B1 (ko) 2015-11-27
ITRM20060498A1 (it) 2008-03-21
CN101553565B (zh) 2015-05-06
IL197575A0 (en) 2011-08-01
ES2435080T3 (es) 2013-12-18
EA200970294A1 (ru) 2009-10-30
IL197575A (en) 2013-06-27
HK1138315A1 (en) 2010-08-20
ZA200901748B (en) 2010-03-31
KR20090074044A (ko) 2009-07-03
CN101553565A (zh) 2009-10-07
US20100068189A1 (en) 2010-03-18
CA2663072C (en) 2016-01-19
WO2008034740A1 (en) 2008-03-27
AU2007299043A1 (en) 2008-03-27
JP5340941B2 (ja) 2013-11-13
US8263400B2 (en) 2012-09-11
RS53039B (sr) 2014-04-30
US20120308535A1 (en) 2012-12-06
EP2076588A1 (en) 2009-07-08
MX2009003059A (es) 2009-04-01
AU2007299043B2 (en) 2013-06-27
BRPI0715036A2 (pt) 2013-05-28
PL2076588T3 (pl) 2014-01-31
CA2663072A1 (en) 2008-03-27
DK2076588T3 (da) 2013-11-11
EA019305B1 (ru) 2014-02-28
SI2076588T1 (sl) 2013-12-31
JP2010504083A (ja) 2010-02-12
EP2076588B1 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
HRP20131104T1 (hr) Metoda širenja za odrasle matiäśne stanice iz krvi, posebno periferne krvi, te relativna uporaba u medicinskom podruäśju
Yamanaka et al. Preventive effects of dexmedetomidine on the development of cognitive dysfunction following systemic inflammation in aged rats
Xu et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis
JP2010504083A5 (cg-RX-API-DMAC7.html)
CN107835695A (zh) 用于治疗自闭症的组合物和方法
KR101401744B1 (ko) Ｎ-아세틸-ｌ-시스테인 또는 이의 유도체를 포함하는 불안 장애 치료용 약학 조성물
JP2021527669A (ja) 線維症の軽減又は治療のための組成物及び方法
EP3341739A1 (en) Mutant peptides and methods of treating subjects using the same
CA2714401C (en) Composition comprising extracts of biota orientalis and use thereof for treating cartilage inflammation
WO2022042541A1 (zh) 眼镜蛇蛇毒或其提取物在制备降尿酸和/或抗痛风性关节炎的药物中的应用
WO2011091461A1 (de) Verbindungen zur verwendung bei der behandlung von erkrankungen
WO2024035859A1 (en) Combination therapies for treating inflammation
US11980624B2 (en) Methods for administering compositions comprising hydroxytyrosol and boswellic acid
Raghu et al. Evaluation of in-vitro and in-vivo anti-inflammatory activities of apigenin and vitexin
TW201720461A (zh) 預防或治療脂肪胰、改善脂肪胰引起的胰病變、糖尿病或其他相關病症之組合物及方法
TWI531366B (zh) 牛樟芝在關節炎、軟骨破壞或軟骨細胞死亡的改善或預防的功效
Shahid et al. Ameliorative Effect of Vitamin D on Articular Cartilage Thickness in Arthritic Rat Model
US20240293464A1 (en) Tissue repair
CN117599062B (zh) 一种辅助改善记忆、预防或治疗阿尔茨海默病的组合物
JP2006241051A (ja) 抗ストレス剤
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
EP1370263B1 (en) Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
TWI645083B (zh) 篩選抑制發炎反應及血管保護活性物質之方法
BR0316192A (pt) Método e composições para o tratamento da ansiedade
TW202416945A (zh) 用於治療發炎之組合療法